Condition: Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8 · Sponsor: NRG Oncology
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham Cancer Center | Birmingham, Alabama, United States | Recruiting |
| The Kirklin Clinic at Acton Road | Birmingham, Alabama, United States | Recruiting |
| Lewis and Faye Manderson Cancer Center | Tuscaloosa, Alabama, United States | Recruiting |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| Kaiser Permanente-Deer Valley Medical Center | Antioch, California, United States | Recruiting |
| Tower Cancer Research Foundation | Beverly Hills, California, United States | Recruiting |
| Kaiser Permanente Dublin | Dublin, California, United States | Recruiting |
| Kaiser Permanente-Fremont | Fremont, California, United States | Recruiting |
| Washington Hospital | Fremont, California, United States | Recruiting |
| Fresno Cancer Center | Fresno, California, United States | Recruiting |
| Kaiser Permanente Fresno Orchard Plaza | Fresno, California, United States | Recruiting |
| Kaiser Permanente-Fresno | Fresno, California, United States | Recruiting |
+ 401 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05946213